Cases (n = 232) | Controls (n = 4353) | P value* | |
---|---|---|---|
Mean age ± SD | 77.1 ± 13.5 | 76.9 ± 13.7 | 0.798 |
Age ≥ 65 | 194 (83.6%) | 3,610 (82.9%) | |
Age < 65 | 38 (16.4%) | 743 (17.1%) | |
Women | 157 (67.7%) | 2,950 (67.8%) | 0.975 |
Men | 75 (32.3%) | 1,403 (32.2%) | |
Hospitalization§ | |||
Mental disorders | 72 (31.0%) | 468 (10.8%) | <.001 |
Coronary heart disease | 22 (9.5%) | 114 (2.6%) | <.001 |
Heart failure | 21 (9.1%) | 118 (2.7%) | <.001 |
Stroke | 12 (5.2%) | 108 (2.5%) | 0.012 |
Chronic liver disease | 5 (2.2%) | 19 (0.4%) | 0.000 |
Parkinson’s disease | 32 (13.8%) | 481 (11.0%) | 0.197 |
Chronic renal disease | 20 (8.6%) | 90 (2.1%) | <.001 |
Drug use§ | |||
Lithium | 5 (2.2%) | 84 (1.9%) | 0.808 |
Statins | 39 (16.8%) | 744 (17.1%) | 0.912 |
NSAIDs | 67 (28.9%) | 1,036 (23.8%) | 0.078 |
Antiplatelet treatment | 123 (53.0%) | 1,981 (45.5%) | 0.025 |
Anti-diabetic | 34 (14.7%) | 613 (14.1%) | 0.807 |
Antihypertensive agents | 155 (66.8%) | 2,608 (59.9%) | 0.036 |